Source: DGNews  |  Posted 8 years ago

-- Approval Provides Full Market Participation

-- Third FDA Approval in Thirteen Months

-- Company Provides Information on Fourth Quarter/Year-ended 2002

FORT COLLINS, CO -- February 18, 2003 -- Atrix Laboratories, Inc. (Nasdaq: ATRX) announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) for Eligard